iFyber LLC
iFyber is a global contract research organization (CRO) specializing in preclinical testing solutions across various industries, including medical devices, wound care, diagnostics, and specialty textiles. The company emphasizes a personalized approach, integrating scientific expertise with high-touch support to accelerate research and development initiatives. iFyber's mission is to enhance innovation and improve healthcare outcomes by providing tailored solutions that meet the unique needs of its clients.
Industries
Nr. of Employees
small (1-50)
iFyber LLC
Products
Porous SERS membrane (porous SERS substrate)
Proprietary porous surface-enhanced Raman substrate designed to increase sensitivity and specificity of Raman-based chemical detection assays.
Porous SERS membrane (porous SERS substrate)
Proprietary porous surface-enhanced Raman substrate designed to increase sensitivity and specificity of Raman-based chemical detection assays.
Services
Laboratory testing and method development for biofilm testing, antimicrobial efficacy (MIC/MBC, time-kill, ZOI, AATCC 100), and sterilization validation.
Development and execution of cell-based assays, 2D/3D tissue models, biocompatibility screening, endotoxin/pyrogen testing, and recellularization assays.
Compositional analysis, bioassays and potency testing, materials testing, functional/mechanical testing, and biomarker analysis using a broad set of analytical techniques.
Viral infectivity testing, titer determination (TCID50/PFU), viral clearance studies, and viral inactivation testing performed in BSL-2 facilities.
Customized sterilization validation planning and execution (development, verification, validation, and regulatory submission phases) for terminal sterilization methods including supercritical CO2.
Tissue processing, sectioning, routine and special stains, immunohistochemistry, in situ hybridization, confocal microscopy, whole-slide scanning, and image analysis.
Laboratory testing and method development for biofilm testing, antimicrobial efficacy (MIC/MBC, time-kill, ZOI, AATCC 100), and sterilization validation.
Development and execution of cell-based assays, 2D/3D tissue models, biocompatibility screening, endotoxin/pyrogen testing, and recellularization assays.
Compositional analysis, bioassays and potency testing, materials testing, functional/mechanical testing, and biomarker analysis using a broad set of analytical techniques.
Viral infectivity testing, titer determination (TCID50/PFU), viral clearance studies, and viral inactivation testing performed in BSL-2 facilities.
Customized sterilization validation planning and execution (development, verification, validation, and regulatory submission phases) for terminal sterilization methods including supercritical CO2.
Tissue processing, sectioning, routine and special stains, immunohistochemistry, in situ hybridization, confocal microscopy, whole-slide scanning, and image analysis.
Expertise Areas
- Preclinical CRO services
- Assay development and verification (IVD/LDT)
- Microbial control and biofilm testing
- Sterilization validation and novel sterilization methods
Key Technologies
- qPCR / RT-qPCR
- Loop-mediated isothermal amplification (LAMP)
- Lateral flow assay development
- Enzyme-linked immunosorbent assay (ELISA)
News & Updates
Raman microscopy is revolutionizing the field of biotechnology by providing high-resolution chemical and structural information.
Viral clearance testing is crucial for ensuring the safety and efficacy of biotherapeutic products.
MedTech companies are evolving to meet patient needs and improve efficiency in R&D.
Raman microscopy is revolutionizing the field of biotechnology by providing high-resolution chemical and structural information.
Viral clearance testing is crucial for ensuring the safety and efficacy of biotherapeutic products.
MedTech companies are evolving to meet patient needs and improve efficiency in R&D.